Inici › Melanoma › Texas › Dallas
Assaigs clínics de Melanoma a Dallas, TX
20 estudis de Melanoma busquen participants en centres de Dallas i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
DESTINY-PANTUMOUR04
ReclutantEstudi observacional
- Research Site, Dallas
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
ReclutantFase 3
- Texas Oncology - Medical City, Dallas
- Texas Oncology, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
ReclutantFase 1/2
- Baylor, Scott and White Research Institute, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
ReclutantEstudi observacional
- UT Southwestern Medical Center, Dallas
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
ReclutantFase 1/2
- UT Southwestern, Dallas
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
ReclutantFase 1/2
- Texas Oncology - Dallas SCRI, Dallas
Project: Every Child for Younger Patients With Cancer
ReclutantEstudi observacional
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutantFase 1/2
- Texas Oncology, P.A., Dallas
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
ReclutantFase 1/2
- Call for Information (Investigational Site 0054), Dallas
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
ReclutantEstudi observacional
- University of Texas Southwestern Medical Center, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutantFase 1/2
- Mary Crowley Cancer Research, Dallas
Neoadjuvant Darovasertib in Primary Uveal Melanoma
ReclutantFase 3
- Texas Retina Associates - Dallas, Dallas
- University of Texas Southwestern Medical Center-5323 Harry Hines Blvd, Dallas
A Study of VET3-TGI in Patients With Solid Tumors
ReclutantFase 1
- Mary Crowley Cancer Research, Dallas
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ReclutantFase 2/3
- UT Southwestern Medical Center, Dallas
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
ReclutantFase 1/2
- Research Site, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
ReclutantFase 1
- NEXT Dallas, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutantFase 1/2
- Research Site 120, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Dallas
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
ReclutantFase 1/2
- Mary Crowley Cancer Research, Dallas
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
ReclutantFase 1
- NEXT Oncology, Dallas, Dallas
Assaigs de Melanoma en altres ciutats
- Houston, TX59 estudis
- New York City, NY38 estudis
- Los Angeles, CA34 estudis
- Nashville, TN33 estudis
- Pittsburgh, PA31 estudis
- Boston, MA26 estudis
- Philadelphia, PA23 estudis
- San Francisco, CA22 estudis
- Durham, NC21 estudis
- Atlanta, GA21 estudis
- St. Louis, MO21 estudis
- Salt Lake City, UT21 estudis
Altres estudis a Dallas
- Càncer de mama55 estudis
- Càncer de pulmó de cèl·lules no petites52 estudis
- Càncer metastàtic42 estudis
- Insuficiència cardíaca42 estudis
- Càncer (tots els tipus)37 estudis
- Càncer de pròstata36 estudis
- Càncer colorrectal33 estudis
- Obesitat30 estudis
- Càncer d'ovari28 estudis
- Càncer de bufeta27 estudis
- Càncer de pulmó27 estudis
- Càncer d'endometri24 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.